Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000635022 | SCV000756400 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2024-05-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492966 | SCV002782081 | uncertain significance | Epilepsy, childhood absence, susceptibility to, 6; Hyperaldosteronism, familial, type IV | 2024-05-15 | criteria provided, single submitter | clinical testing | |
Genome |
RCV000635022 | SCV004228765 | not provided | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 11-27-2020 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. |